Interpace Biosciences Inc
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $16.4M | $14.2M | $2.1M | $1.5M |
| FY2011 | $2.0M | $1.6M | $343.0K | $1.9M |
| FY2012 | $-10.3M | $-11.4M | $1.1M | $1.8M |
| FY2013 | $-3.5M | $-5.3M | $1.8M | $1.7M |
| FY2014 | $-16.4M | $-19.2M | $2.9M | $2.1M |
| FY2015 | $-19.8M | $-20.2M | $353.0K | $4.0M |
| FY2016 | $-7.6M | $-7.6M | — | $131.0K |
| FY2017 | $-15.3M | $-15.3M | $29.0K | $1.1M |
| FY2018 | $-8.7M | $-9.1M | $449.0K | $2.3M |
| FY2019 | $-19.0M | $-19.1M | $131.0K | $1.5M |
| FY2020 | $-14.0M | $-15.6M | $1.6M | $2.2M |
| FY2021 | $-8.7M | $-9.1M | $354.0K | $1.3M |
| FY2022 | $-7.7M | $-8.0M | $322.0K | $1.3M |
| FY2023 | $3.8M | $3.3M | $470.0K | $630.0K |
| FY2024 | $4.6M | $3.8M | $876.0K | $291.0K |
| FY2025 | $5.8M | $5.5M | $356.0K | $35.0K |